WRAP TECHNOLOGIES INC (WRAP)

US98212N1072 - Common Stock

1.69  +0.14 (+8.68%)

After market: 1.78 +0.09 (+5.33%)

Fundamental Rating

3

Overall WRAP gets a fundamental rating of 3 out of 10. We evaluated WRAP against 127 industry peers in the Electronic Equipment, Instruments & Components industry. WRAP scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages. WRAP is quite expensive at the moment. It does show a decent growth rate.



1

1. Profitability

1.1 Basic Checks

WRAP had negative earnings in the past year.
WRAP had a negative operating cash flow in the past year.
WRAP had negative earnings in each of the past 5 years.
WRAP had a negative operating cash flow in each of the past 5 years.

1.2 Ratios

The Return On Assets of WRAP (-48.50%) is worse than 80.95% of its industry peers.
WRAP has a worse Return On Equity (-74.67%) than 82.54% of its industry peers.
Industry RankSector Rank
ROA -48.5%
ROE -74.67%
ROIC N/A
ROA(3y)-46.23%
ROA(5y)-41.12%
ROE(3y)-50.49%
ROE(5y)-44.36%
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

WRAP has a Gross Margin of 53.67%. This is amongst the best in the industry. WRAP outperforms 91.27% of its industry peers.
In the last couple of years the Gross Margin of WRAP has grown nicely.
The Profit Margin and Operating Margin are not available for WRAP so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 53.67%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y5.02%
GM growth 5YN/A

5

2. Health

2.1 Basic Checks

WRAP does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, WRAP has more shares outstanding
Compared to 5 years ago, WRAP has more shares outstanding
There is no outstanding debt for WRAP. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.

2.2 Solvency

WRAP has an Altman-Z score of -0.25. This is a bad value and indicates that WRAP is not financially healthy and even has some risk of bankruptcy.
WRAP has a Altman-Z score of -0.25. This is in the lower half of the industry: WRAP underperforms 76.19% of its industry peers.
There is no outstanding debt for WRAP. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z -0.25
ROIC/WACCN/A
WACC9.22%

2.3 Liquidity

WRAP has a Current Ratio of 2.39. This indicates that WRAP is financially healthy and has no problem in meeting its short term obligations.
WRAP has a Current ratio (2.39) which is comparable to the rest of the industry.
A Quick Ratio of 1.85 indicates that WRAP should not have too much problems paying its short term obligations.
WRAP's Quick ratio of 1.85 is in line compared to the rest of the industry. WRAP outperforms 55.56% of its industry peers.
Industry RankSector Rank
Current Ratio 2.39
Quick Ratio 1.85

4

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 24.05% over the past year.
The Revenue has grown by 31.94% in the past year. This is a very strong growth!
The Revenue has been growing by 125.72% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)24.05%
EPS 3YN/A
EPS 5YN/A
EPS growth Q2Q46.81%
Revenue 1Y (TTM)31.94%
Revenue growth 3Y125.72%
Revenue growth 5YN/A
Revenue growth Q2Q113.53%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y3.64%
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year14.51%
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for WRAP. In the last year negative earnings were reported.
Also next year WRAP is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

No dividends for WRAP!.
Industry RankSector Rank
Dividend Yield N/A

WRAP TECHNOLOGIES INC

NASDAQ:WRAP (5/3/2024, 7:26:45 PM)

After market: 1.78 +0.09 (+5.33%)

1.69

+0.14 (+8.68%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupTechnology Hardware & Equipment
GICS IndustryElectronic Equipment, Instruments & Components
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap74.71M
Analysts
Price Target
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S
P/FCF
P/OCF
P/B
P/tB
EV/EBITDA
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -48.5%
ROE -74.67%
ROCE
ROIC
ROICexc
ROICexgc
OM N/A
PM (TTM) N/A
GM 53.67%
FCFM
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover0.29
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF
Debt/EBITDA
Cap/Depr
Cap/Sales
Interest Coverage
Cash Conversion
Profit Quality
Current Ratio 2.39
Quick Ratio 1.85
Altman-Z
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
Growth
EPS 1Y (TTM)24.05%
EPS 3YN/A
EPS 5Y
EPS growth Q2Q
EPS Next Y3.64%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)31.94%
Revenue growth 3Y125.72%
Revenue growth 5Y
Revenue growth Q2Q
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y